272 related articles for article (PubMed ID: 20848731)
1. Multiple metastases from cutaneous malignant melanoma patients may display heterogeneous genomic and epigenomic patterns.
Harbst K; Staaf J; Måsbäck A; Olsson H; Ingvar C; Vallon-Christersson J; Ringnér M; Borg A; Jönsson G
Melanoma Res; 2010 Oct; 20(5):381-91. PubMed ID: 20848731
[TBL] [Abstract][Full Text] [Related]
2. Identification of novel epigenetically modified genes in human melanoma via promoter methylation gene profiling.
Liu S; Ren S; Howell P; Fodstad O; Riker AI
Pigment Cell Melanoma Res; 2008 Oct; 21(5):545-58. PubMed ID: 18627528
[TBL] [Abstract][Full Text] [Related]
3. Gene expression profiling of primary cutaneous melanoma.
Winnepenninckx V; Van den Oord JJ
Verh K Acad Geneeskd Belg; 2007; 69(1):23-45. PubMed ID: 17427873
[TBL] [Abstract][Full Text] [Related]
4. Genetically heterogeneous and clonally unrelated metastases may arise in patients with cutaneous melanoma.
Katona TM; Jones TD; Wang M; Eble JN; Billings SD; Cheng L
Am J Surg Pathol; 2007 Jul; 31(7):1029-37. PubMed ID: 17592269
[TBL] [Abstract][Full Text] [Related]
5. Genomic profiling of malignant melanoma using tiling-resolution arrayCGH.
Jönsson G; Dahl C; Staaf J; Sandberg T; Bendahl PO; Ringnér M; Guldberg P; Borg A
Oncogene; 2007 Jul; 26(32):4738-48. PubMed ID: 17260012
[TBL] [Abstract][Full Text] [Related]
6. Gene expression profiling of primary cutaneous melanoma and clinical outcome.
Winnepenninckx V; Lazar V; Michiels S; Dessen P; Stas M; Alonso SR; Avril MF; Ortiz Romero PL; Robert T; Balacescu O; Eggermont AM; Lenoir G; Sarasin A; Tursz T; van den Oord JJ; Spatz A;
J Natl Cancer Inst; 2006 Apr; 98(7):472-82. PubMed ID: 16595783
[TBL] [Abstract][Full Text] [Related]
7. Loss of heterozygosity in the MXI1 gene is a frequent occurrence in melanoma.
Ariyanayagam-Baksh SM; Baksh FK; Swalsky PA; Finkelstein SD
Mod Pathol; 2003 Oct; 16(10):992-5. PubMed ID: 14559981
[TBL] [Abstract][Full Text] [Related]
8. Chromosomal gains and losses in primary cutaneous melanomas detected by comparative genomic hybridization.
Bastian BC; LeBoit PE; Hamm H; Bröcker EB; Pinkel D
Cancer Res; 1998 May; 58(10):2170-5. PubMed ID: 9605762
[TBL] [Abstract][Full Text] [Related]
9. Concomitant loss of chromosome 3 and whole arm losses and gains of chromosome 1, 6, or 8 in metastasizing primary uveal melanoma.
Aalto Y; Eriksson L; Seregard S; Larsson O; Knuutila S
Invest Ophthalmol Vis Sci; 2001 Feb; 42(2):313-7. PubMed ID: 11157859
[TBL] [Abstract][Full Text] [Related]
10. Use of microgenomic technology for analysis of alterations in DNA copy number and gene expression in malignant melanoma.
Trent JM; Bittner M; Zhang J; Wiltshire R; Ray M; Su Y; Gracia E; Meltzer P; De Risi J; Penland L; Brown P
Clin Exp Immunol; 1997 Jan; 107 Suppl 1():33-40. PubMed ID: 9020934
[TBL] [Abstract][Full Text] [Related]
11. Somatic alterations in the melanoma genome: a high-resolution array-based comparative genomic hybridization study.
Gast A; Scherer D; Chen B; Bloethner S; Melchert S; Sucker A; Hemminki K; Schadendorf D; Kumar R
Genes Chromosomes Cancer; 2010 Aug; 49(8):733-45. PubMed ID: 20544847
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic inactivation of RAS association domain family protein 1 (RASSF1A) in malignant cutaneous melanoma.
Spugnardi M; Tommasi S; Dammann R; Pfeifer GP; Hoon DS
Cancer Res; 2003 Apr; 63(7):1639-43. PubMed ID: 12670917
[TBL] [Abstract][Full Text] [Related]
13. Additional Cyclin D(1) gene copies associated with chromosome 11 aberrations in cutaneous malignant melanoma.
Utikal J; Udart M; Leiter U; Peter RU; Krähn G
Int J Oncol; 2005 Mar; 26(3):597-605. PubMed ID: 15703813
[TBL] [Abstract][Full Text] [Related]
14. Biallelic deletions in INK4 in cutaneous melanoma are common and associated with decreased survival.
Grafström E; Egyházi S; Ringborg U; Hansson J; Platz A
Clin Cancer Res; 2005 Apr; 11(8):2991-7. PubMed ID: 15837753
[TBL] [Abstract][Full Text] [Related]
15. Low frequency of p16/CDKN2A methylation in sporadic melanoma: comparative approaches for methylation analysis of primary tumors.
Gonzalgo ML; Bender CM; You EH; Glendening JM; Flores JF; Walker GJ; Hayward NK; Jones PA; Fountain JW
Cancer Res; 1997 Dec; 57(23):5336-47. PubMed ID: 9393758
[TBL] [Abstract][Full Text] [Related]
16. Significance of gene expression analysis in uveal melanoma in comparison to standard risk factors for risk assessment of subsequent metastases.
Petrausch U; Martus P; Tönnies H; Bechrakis NE; Lenze D; Wansel S; Hummel M; Bornfeld N; Thiel E; Foerster MH; Keilholz U
Eye (Lond); 2008 Aug; 22(8):997-1007. PubMed ID: 17384575
[TBL] [Abstract][Full Text] [Related]
17. Gene expression signatures for tumor progression, tumor subtype, and tumor thickness in laser-microdissected melanoma tissues.
Jaeger J; Koczan D; Thiesen HJ; Ibrahim SM; Gross G; Spang R; Kunz M
Clin Cancer Res; 2007 Feb; 13(3):806-15. PubMed ID: 17289871
[TBL] [Abstract][Full Text] [Related]
18. Genetic heterogeneity and clonal evolution underlying development of asynchronous metastasis in human breast cancer.
Kuukasjärvi T; Karhu R; Tanner M; Kähkönen M; Schäffer A; Nupponen N; Pennanen S; Kallioniemi A; Kallioniemi OP; Isola J
Cancer Res; 1997 Apr; 57(8):1597-604. PubMed ID: 9108466
[TBL] [Abstract][Full Text] [Related]
19. Conservation of genetic alterations in recurrent melanoma supports the melanoma stem cell hypothesis.
Sabatino M; Zhao Y; Voiculescu S; Monaco A; Robbins P; Karai L; Nickoloff BJ; Maio M; Selleri S; Marincola FM; Wang E
Cancer Res; 2008 Jan; 68(1):122-31. PubMed ID: 18172304
[TBL] [Abstract][Full Text] [Related]
20. High expression of DNA repair pathways is associated with metastasis in melanoma patients.
Kauffmann A; Rosselli F; Lazar V; Winnepenninckx V; Mansuet-Lupo A; Dessen P; van den Oord JJ; Spatz A; Sarasin A
Oncogene; 2008 Jan; 27(5):565-73. PubMed ID: 17891185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
